| Ytd | 40.05% | |
| 1y | 14.92% |
| Open | 22.65 | Prev Close | 22.99 | Low | 22.00 | High | 22.75 | Mkt Cap | 1.37B |
| Vol | 314.35K | Avg Vol | 1.14M | EPS | 0.07 | P/E | 328.43 | Forward P/E | 769.23 |
| Beta | N/A | Short Ratio | 6.99 | Inst. Own | 81.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.11 | 200-d Avg | 17.17 | 1yr Est | 23.75 |
OMDA News
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raise
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Wall Street analysts change outlook on top stocks. For detailed ratings, upgrades/downgrades, see an
BTIG analyst David Larsen initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
SAN FRANCISCO, July 15, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-vi
Morgan Stanley analyst Craig Hettenbach reiterates Omada Health (NASDAQ:OMDA) with a Overweight a
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperf
Wells Fargo analyst Stan Berenshteyn maintains Omada Health (NASDAQ:OMDA) with a Equal-Weight and
Omada Health (NASDAQ:OMDA) announced it will serve as an independent program administrator in Eli Li
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $312.000 million-$322.000 million to $32
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst con
Research has shown that during gradual weight loss from lifestyle interventions and older weight los
Citizens analyst Constantine Davides initiates coverage on Omada Health (NASDAQ:OMDA) with a Mark
